Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Kidney Int. 2014 Feb 26;86(1):139–145. doi: 10.1038/ki.2014.14

Table 2.

Comparison of various measurements (symbols are same as in table 1) between WT and β4KO on control, Alk, or Acid diets and treated with vehicle (veh), hydrochlorothiazide (HCTZ), or amiloride (amil).

KW V U[K] U[Na] P[K] P[Na] Uosm Posm Hct. UpH
units mgm N ml/day N mM N mM N mM N mM N mOsm/L N mOsm/L N % N N
WT-veh 275 4 1.3 4 298 4 62.3 4 4.32 4 158.1 4 2180 4 277.5 4 40.8 4 6.17 4
±SEM 10 0.24 82.3 5 0.15 0.8 410 2.5 1.5 0.09
WT-HCTZ 273 8 1.66 7 282 7 137.9 7 4.19 8 154.9 7 2141 7 297.5 8 42.6 3 6.24 7
±SEM 11 0.27 66.9 35.5 0.11 1.7 440 4.9 1.9 0.19
WT-amil 282 4 2.4 4 110 4 244.5 4 5.81 4 140.3 4 1670 4 282.5 4 46.7 4 6.3 4
±SEM 8 0.35 39 20.9 0.22 1.6 385 2.5 1.9 0.11
WT-Alk-veh 276 9 2 9 716 9 4.44 9 5.62 9 147.4 7 2339 9 291.1 9 40.4 9 7.31 9
±SEM 8 0.34 93.4 1.01 0.23 1.6 376 3.1 1.1 0.32
WT-Alk-HCTZ 274 4 2.15 4 487 4 3.55 4 4.89 4 146.9 4 1647 4 277.5 4 42.9 4 7.18 4
±SEM 10 0.35 75.5 0.76 0.21 2.1 145 2.5 1.6 0.51
WT-Alk-amil 256 8 1.78 8 282 6 184.2 8 7.2 8 135.7 8 1657 8 280 8 49.2 7 6 8
±SEM 1 0.18 37 17.5 0.05 0.8 201 2.7 1 0.25
KO-Alk-veh 248 7 1,61 7 373 7 4.79 7 5.67 7 150 6 1769 7 284 7 39 7 6.32 7
±SEM 14 0.24 94 0.95 0.28 2 280 3.7 0.8 0.25
KO-Alk-HCTZ 244 5 1.8 4 253 4 4.01 4 5.04 5 148.3 4 1225 4 302 5 38.3 3 6.34 4
±SEM 8 0.11 35 0.64 0.37 1.1 118 4 1.9 0.08
KO-Alk-amil 225 5 0.64 5 528 5 448 5 7.55 5 132.5 5 3137 5 290 5 47.2 4 6.25 5
±SEM 3 0.02 63.6 24.9 0.63 1 409 3.2 1.2 0.14